Silver Spring, Maryland, United States Lung Biotechnology is the famous Corporate Investor, which was founded in 1997. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Silver Spring.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the Lung Biotechnology, startups are often financed by Kleiner Perkins, Flagship Pioneering, Abrams Capital. The meaningful sponsors for the fund in investment in the same round are Kleiner Perkins, Inbio Ventures, Flagship Pioneering. In the next rounds fund is usually obtained by Pharmstandard, Kleiner Perkins, Inbio Ventures.
The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2016.
Besides, a startup needs to be aged 16-20 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline TransMedics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Medical, Health Care.
| Fund Name | Location |
| 724 Solutions | Canada, Ontario, Toronto |
| Aream & Co | England, London, United Kingdom |
| BOCOM International | China, Hong Kong, Hong Kong Island |
| Citrosuco | - |
| Fengshi Equity Investment Management | China, Shanghai |
| Future Corp | Japan, Tokyo |
| hackNY | New York, New York, United States |
| Norsk Hydro ASA | Norway, Oslo |
| PointGuard Ventures | California, Menlo Park, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 